The Analyst Landscape: 5 Takes On Omnicell
The Analyst Landscape: 5 Takes On Omnicell
分析师领域：关于Omnicell的5个观点
The perception of Omnicell by financial experts is analyzed through recent analyst...Analysts' ratings for Omnicell (NASDAQ:OMCL) over the last quarter vary from bullish to bearish, as provided by 5 analysts.
过去一个季度，对Omnicell (纳斯达克: OMCL) 的分析师评级从看好到看淡，由5位分析师提供。
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
以下表格总结了分析师们最近的评级，揭示了过去30天内情绪的变化并将其与前几个月进行了比较。
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $37.6, along with a high estimate of $44.00 and a low estimate of $30.00. Marking an increase of 25.33%, the current average surpasses the previous average price target of $30.00.
Omnicell Inc为医疗保健提供自动化和商业分析软件。它帮助客户定义和提供成本效益的药物管理，旨在使药剂师和护士专注于患者护理而不是行政任务，并推动改善临床、运营和财务结果，覆盖所有护理环境。Omnicell绝大部分营业收入来自美国。
Analyzing Analyst Ratings: A Detailed Breakdown
分析分析师评级：详细剖析
The perception of Omnicell by financial experts is analyzed through recent analyst...
营业收入下降：在3个月的...
登录免费看全文
登录/注册
资讯热榜
更新时间